ClinicalTrials.Veeva

Menu

Phenylephrine Versus Norepinephrine in Ophthalmic Surgery

U

University Medical Center Groningen (UMCG)

Status

Completed

Conditions

Bloodpressure

Treatments

Drug: phenylephrine
Drug: norepinephrine

Study type

Interventional

Funder types

Other

Identifiers

NCT01609491
PheNor-001

Details and patient eligibility

About

In ophthalmic surgery the specific anaesthesiological challenges necessitate the administration of a combination of relatively high doses of hypnotics and analgetics. In order to preserve adequate organ perfusion, there is often a need to administer pharmacological agents for haemodynamic support. Depending on the experience of the anaesthetist a continuous infusion of phenylephrine or norepinephrine is used. It is currently not known which of these agents has the most favorable haemodynamical profile.

Haemodynamic parameters (continuous blood pressure, cardiac index, stroke volume and systemic resistance), peripheral tissue oxygenation and cerebral tissue oxygenation will be monitored noninvasively using the Nexfin® , Inspectra®, and Foresight® and O2C® monitoring devices.

Enrollment

60 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients requiring general anaesthesia for ophthalmic surgery.

  • Age > 18 years and older
  • Diabetes or cardiovascular disease or age >55 years

Exclusion criteria

  • Patient refusal
  • Patient < 18 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

60 participants in 2 patient groups

phenylephrine
Active Comparator group
Description:
If the mean arterial pressure drops below 20% of the baseline value and/or below 90 mmHg, a syringe pump with phenylephrine will be started. The anaesthetist will be blinded for the type of vasopressor. Concentrations phenylephrine (20 µg /ml) will be used in the syringes
Treatment:
Drug: phenylephrine
norepinephrine
Active Comparator group
Description:
If the mean arterial pressure drops below 20% of the baseline value and/or below 90 mmHg, a syringe pump with norepinephrine (depending on randomisation) will be started. The anaesthetist will be blinded for the type of vasopressor. Concentrations Norepinephrine (10 µg/ml) will be used in the syringes
Treatment:
Drug: norepinephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems